サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1771586

米国の創傷ジェル市場規模・シェア・動向分析レポート：製品別、抗菌特性別、用途別、最終用途別、購入モード別、流通チャネル別、セグメント予測、2025年～2033年

U.S. Wound Gel Market Size, Share & Trends Analysis Report By Product (Dressings, Gels), By Antimicrobial Properties (Silver (Ag+), Non-Silver), By Application, By End-use, By Mode Of Purchase, By Distribution Channel, And Segment Forecasts, 2025 - 2033

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
米国の創傷ジェル市場規模・シェア・動向分析レポート：製品別、抗菌特性別、用途別、最終用途別、購入モード別、流通チャネル別、セグメント予測、2025年～2033年
出版日: 2025年06月16日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

米国の創傷ジェル市場規模・動向：

米国の創傷ジェル市場規模は2024年に21億1,000万米ドルと推定され、2025年から2033年にかけてCAGR 5.71％で成長し、2033年には34億7,000万米ドルに達すると予測されています。

この成長の背景には、慢性創傷の有病率の上昇、高度な創傷ケアソリューションに対する需要の増加、高齢者人口の増加、治癒効果を高めるハイドロゲル製剤の継続的な技術革新があります。加えて、外来および在宅ケアへのシフトと支援的な償還政策が市場拡大をさらに加速させています。

米国国勢調査局のデータによると、2025年までに人口の平均年齢は40歳に達し、65歳以上の高齢者は約6,000万人で総人口の18％を占めると予想されています。そのうち4％が80歳以上となります。2050年には、高齢者の数は8,000万人に増加し、65歳以上の人口の25％を占め、80歳以上は8％を占めると予測されています。

米国の軍事・防衛分野における創傷ジェル製品に対する需要の増加は、主に戦闘や現場での活動という特殊でリスクの高い性質のため、重要な市場促進要因として浮上しています。軍人は裂傷、火傷、深い傷などの外傷に頻繁にさらされ、従来の外科的治療が容易に受けられない過酷な環境では、即効性があり、効率的で、感染に強い治療が必要となります。このような状況において、創傷ジェルは実用的な解決策を提供します。携帯可能で、塗布が簡単で、保湿性治癒環境を提供し、感染リスクを最小限に抑えながら、組織の再生を早める。

さらに、米国国防総省はバイオテクノロジー企業と協力し、戦場での使用に特化した酵素ベースや抗菌性の創傷ジェルなど、先進的なハイドロゲル製剤を開発しています。例えば、米国陸軍は2024年11月、ケンブリッジに本拠を置くバイオテクノロジー企業SolasCure社と提携し、同社の創傷治療用ハイドロゲルAurase Wound Gelを軍事環境で評価することを決定しました。オーラセ創傷ジェルは、当初ウジ虫由来の組換え酵素タルマーゼを特徴としています。この酵素は、死んだ組織を除去し、創傷床を整える酵素的剥離に非常に効果的で、自然治癒や代替治療のアプローチをサポートする創傷管理のための生物学的着想を得たソリューションを提供します。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 米国の創傷ジェル市場の変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 補助市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題分析
  • 米国の創傷ジェル市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 米国の創傷ジェル市場：製品の推定・動向分析

  • セグメントダッシュボード
  • 米国の創傷ジェル市場変動分析
  • 米国の創傷ジェル市場規模と動向分析（製品別、2021年～2033年）
  • ドレッシング
    • ハイドロゲルドレッシング
    • ゲル化繊維ドレッシング
    • その他
  • ゲル

第5章 米国の創傷ジェル市場：抗菌特性の推定・動向分析

  • セグメントダッシュボード
  • 米国の創傷ジェル市場変動分析
  • 米国の創傷ジェル市場規模と動向分析（抗菌特性別、2021～2033年）
  • 銀（Ag+）
  • 銀以外

第6章 米国の創傷ジェル市場：用途の推定・動向分析

  • セグメントダッシュボード
  • 米国の創傷ジェル市場変動分析
  • 米国の創傷ジェル市場規模と動向分析（用途別、2021～2033年）
  • 慢性創傷
    • 糖尿病性足潰瘍（DFU）
    • 褥瘡
    • 脚の潰瘍
  • 急性創傷
    • 外科的切開
    • 火傷
    • 裂傷、擦り傷

第7章 米国の創傷ジェル市場：流通チャネルの推定・動向分析

  • セグメントダッシュボード
  • 米国の創傷ジェル市場変動分析
  • 米国の創傷ジェル市場規模と動向分析（流通チャネル別、2021～2033年）
  • オンライン
  • オフライン

第8章 米国の創傷ジェル市場：購入モードの推定・動向分析

  • セグメントダッシュボード
  • 米国の創傷ジェル市場変動分析
  • 米国の創傷ジェル市場規模と動向分析（購入モード別、2021～2033年）
  • 処方箋
  • 処方箋なし

第9章 米国の創傷ジェル市場：最終用途の推定・動向分析

  • セグメントダッシュボード
  • 米国の創傷ジェル市場変動分析
  • 米国の創傷ジェル市場規模と動向分析（最終用途別、2021～2033年）
  • 病院
  • 専門クリニック
  • 外来手術センター
  • 在宅ケア設定
  • 長期ケア施設
  • その他

第10章 競合情勢

  • 市場参入企業の分類
  • 主要企業プロファイル
  • Company Share Analysis, 2024
    • Medline Industries, LP.
    • Coloplast Corp
    • Molnlycke Health Care AB
    • Solventum
    • Convatec Inc.
    • Cresilon
    • Smith+Nephew
    • B. Braun SE
    • DermaRite Industries, LLC.
    • Integra LifeSciences Corporation
    • Sanara MedTech Inc.
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. U.S. Wound Gel Market, by Product, 2021 - 2033 (USD Million)
  • Table 4. U.S. Wound Gel Market, by Antimicrobial Properties, 2021 - 2033 (USD Million)
  • Table 5. U.S. Wound Gel Market, by Application, 2021 - 2033 (USD Million)
  • Table 6. U.S. Wound Gel Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 7. U.S. Wound Gel Market, by Mode of Purchase, 2021 - 2033 (USD Million)
  • Table 8. U.S. Wound Gel Market, by End Use, 2021 - 2033 (USD Million)
  • Table 9. Participant's Overview
  • Table 10. Financial Performance
  • Table 11. Product Benchmarking
  • Table 12. Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Wound Gel Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 U.S. Wound Gel Market, for Product, 2021 - 2033 (USD Million)
  • Fig. 15 U.S. Wound Gel Market, for Dressings, 2021 - 2033 (USD Million)
  • Fig. 16 U.S. Wound Gel Market, for Hydrogel Dressing, 2021 - 2033 (USD Million)
  • Fig. 17 U.S. Wound Gel Market, for Gelling Fiber Dressings, 2021 - 2033 (USD Million)
  • Fig. 18 U.S. Wound Gel Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 19 U.S. Wound Gel Market, for Gels, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. Wound Gel Market, for Antimicrobial Properties, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. Wound Gel Market, for Silver (Ag+), 2021 - 2033 (USD Million)
  • Fig. 22 U.S. Wound Gel Market, for Non-Silver, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. Wound Gel Market, for Application, 2021 - 2033 (USD Million)
  • Fig. 24 U.S. Wound Gel Market, for Chronic Wounds, 2021 - 2033 (USD Million)
  • Fig. 25 U.S. Wound Gel Market, for Diabetic Foot Ulcers (DFUs), 2021 - 2033 (USD Million)
  • Fig. 26 U.S. Wound Gel Market, for Pressure Ulcers, 2021 - 2033 (USD Million)
  • Fig. 27 U.S. Wound Gel Market, for Stage 1, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. Wound Gel Market, for Stage 2, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. Wound Gel Market, for Stage 3, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. Wound Gel Market, for Stage 4, 2021 - 2033 (USD Million)
  • Fig. 31 U.S. Wound Gel Market, for Leg Ulcers, 2021 - 2033 (USD Million)
  • Fig. 32 U.S. Wound Gel Market, for Acute Wound, 2021 - 2033 (USD Million)
  • Fig. 33 U.S. Wound Gel Market, for Surgical Incisions, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. Wound Gel Market, for Burns, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. Wound Gel Market, for 1st Degree, 2021 - 2033 (USD Million)
  • Fig. 36 U.S. Wound Gel Market, for 2nd Degree, 2021 - 2033 (USD Million)
  • Fig. 37 U.S. Wound Gel Market, for 3rd Degree, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. Wound Gel Market, for Lacerations, Abrasions, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. Wound Gel Market, for End Use, 2021 - 2033 (USD Million)
  • Fig. 40 U.S. Wound Gel Market, for Hospitals, 2021 - 2033 (USD Million)
  • Fig. 41 U.S. Wound Gel Market, for Specialty Clinics, 2021 - 2033 (USD Million)
  • Fig. 42 U.S. Wound Gel Market, for Ambulatory Surgery Centers, 2021 - 2033 (USD Million)
  • Fig. 43 U.S. Wound Gel Market, for Homecare Settings, 2021 - 2033 (USD Million)
  • Fig. 44 U.S. Wound Gel Market, for Long-Term Care Facilities, 2021 - 2033 (USD Million)
  • Fig. 45 U.S. Wound Gel Market, for Others, 2021 - 2033 (USD Million)
  • Fig. 46 U.S. Wound Gel Market, for Distribution Channel, 2021 - 2033 (USD Million)
  • Fig. 47 U.S. Wound Gel Market, for Offline, 2021 - 2033 (USD Million)
  • Fig. 48 U.S. Wound Gel Market, for Online, 2021 - 2033 (USD Million)
  • Fig. 49 U.S. Wound Gel Market, for Mode of Purchase, 2021 - 2033 (USD Million)
  • Fig. 50 U.S. Wound Gel Market, for Prescription, 2021 - 2033 (USD Million)
  • Fig. 51 U.S. Wound Gel Market, for Non-prescription, 2021
目次
Product Code: GVR-4-68040-621-3

U.S Wound Gel Market Size & Trends:

The U.S. wound gel market size was estimated at USD 2.11 billion in 2024 and is expected to grow at a CAGR of 5.71% from 2025 to 2033 to reach USD 3.47 billion by 2033. This growth is attributed to the rising prevalence of chronic wounds, increasing demand for advanced wound care solutions, a growing elderly population, and continuous innovations in hydrogel formulations that enhance healing outcomes. In addition, the shift toward outpatient and home-based care and supportive reimbursement policies is further accelerating market expansion.

According to data from the U.S. Census Bureau, by 2025, the population's average age is expected to reach 40 years, with approximately 60 million individuals aged 65 years or older accounting for 18% of the total population. Among them, 4% will be 80 years or older. By 2050, the number of elderly individuals is projected to rise to 80 million, representing 25% of the population aged 65 and above, while those aged 80 and over will comprise 8%.

The increasing demand for wound gel products from the U.S. military and defense sector is emerging as a significant market driver, primarily due to combat and field operations' unique and high-risk nature. Military personnel are frequently exposed to traumatic injuries, including lacerations, burns, and deep wounds, which require immediate, efficient, and infection-resistant treatment in austere environments where traditional surgical care is not readily available. In such scenarios, wound gels offer a practical solution-they are portable, easy to apply, and provide moisture-retentive healing environments that promote faster tissue regeneration while minimizing infection risks.

Furthermore, the U.S. Department of Defense has collaborated with biotechnology firms to develop advanced hydrogel formulations, including enzyme-based or antimicrobial wound gels designed specifically for battlefield use. For instance, in November 2024, the U.S. Army partnered with SolasCure, a Cambridge-based biotechnology company, to evaluate the company's investigational wound care hydrogel, Aurase Wound Gel, in military settings. Aurase wound gel features a recombinant enzyme, tarumase, derived initially from maggots. This enzyme is highly effective in enzymatic debridement, removing dead tissue and preparing the wound bed, offering a biologically inspired solution for wound management that supports natural and alternative healing approaches.

U.S. Wound Gel Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. wound gel market report based on product, antimicrobial properties, application, distribution channel, mode of purchase, and end-use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Dressings
    • Hydrogel dressing
    • Gelling fiber dressings
    • Others
  • Gels
  • Antimicrobial Properties Outlook (Revenue, USD Million, 2021 - 2033)
  • Silver (Ag+)
  • Non-Silver
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Chronic Wounds
    • Diabetic Foot Ulcers (DFUs)
    • Pressure Ulcers
    • Stage 1
    • Stage 2
    • Stage 3
    • Stage 4
    • Leg Ulcers
  • Acute Wounds
    • Surgical Incisions
    • Burns
    • 1st Degree
    • 2nd Degree
    • 3rd Degree
    • Lacerations, Abrasions
  • Mode of Purchase Outlook (Revenue, USD Million, 2021 - 2033)
  • Prescription
  • Non-prescription
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Offline
  • Online
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgery Centers
  • Homecare Settings
  • Long-Term Care Facilities
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Antimicrobial Properties
    • 1.2.3. Application
    • 1.2.4. Distribution Channel
    • 1.2.5. Mode of Purchase
    • 1.2.6. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Wound Gel Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Shift towards home healthcare
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Rising Prevalence of Chronic Diseases
      • 3.2.1.4. Rising aging population in the U.S.
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent regulatory environment
      • 3.2.2.2. Limited reimbursement policies
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Increasing demand for wound gel products from the military and defense sector
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Rising competition among industry participants
  • 3.3. U.S. Wound Gel Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. U.S. Wound Gel Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Wound Gel Market Movement Analysis
  • 4.3. U.S. Wound Gel Market Size & Trend Analysis, by Product, 2021 - 2033 (USD Million)
  • 4.4. Dressings
    • 4.4.1. Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Hydrogel Dressing
      • 4.4.2.1. Hydrogel Dressing Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Gelling Fiber Dressings
      • 4.4.3.1. Gelling Fiber Dressings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Gels
    • 4.5.1. Gels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Wound Gel Market: Antimicrobial Properties Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Wound Gel Market Movement Analysis
  • 5.3. U.S. Wound Gel Market Size & Trend Analysis, by Antimicrobial Properties, 2021 to 2033 (USD Million)
  • 5.4. Silver (Ag+)
    • 5.4.1. Silver (Ag+) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Non-Silver
    • 5.5.1. Non-Silver Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Wound Gel Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Wound Gel Market Movement Analysis
  • 6.3. U.S. Wound Gel Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Chronic Wounds
    • 6.4.1. Chronic Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. Diabetic Foot Ulcers (DFUs)
      • 6.4.2.1. Diabetic Foot Ulcers (DFUs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Pressure Ulcers
      • 6.4.3.1. Pressure Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.4.3.2. Stage 1
        • 6.4.3.2.1. Stage 1 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.4.3.3. Stage 2
        • 6.4.3.3.1. Stage 2 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.4.3.4. Stage 3
        • 6.4.3.4.1. Stage 3 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.4.3.5. Stage 4
        • 6.4.3.5.1. Stage 4 Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Leg Ulcers
      • 6.4.4.1. Leg Ulcers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Acute Wounds
    • 6.5.1. Acute Wounds Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. Surgical Incisions
      • 6.5.2.1. Surgical Incisions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Burns
      • 6.5.3.1. Burns Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.2. 1st Degree
        • 6.5.3.2.1. 1st Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.3. 2nd Degree
        • 6.5.3.3.1. 2nd Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.5.3.4. 3rd Degree
        • 6.5.3.4.1. 3rd Degree Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. Lacerations, Abrasions
      • 6.5.4.1. Lacerations, Abrasions Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Wound Gel Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Wound Gel Market Movement Analysis
  • 7.3. U.S. Wound Gel Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 7.4. Online
    • 7.4.1. Online Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Offline
    • 7.5.1. Offline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. U.S. Wound Gel Market: Mode of Purchase Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Wound Gel Market Movement Analysis
  • 8.3. U.S. Wound Gel Market Size & Trend Analysis, by Mode of Purchase, 2021 to 2033 (USD Million)
  • 8.4. Prescription
    • 8.4.1. Prescription Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Non-prescription
    • 8.5.1. Non-prescription Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. U.S. Wound Gel Market: End Use Estimates & Trend Analysis

  • 9.1. Segment Dashboard
  • 9.2. U.S. Wound Gel Market Movement Analysis
  • 9.3. U.S. Wound Gel Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 9.4. Hospitals
    • 9.4.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.5. Specialty Clinics
    • 9.5.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.6. Ambulatory Surgery Center
    • 9.6.1. Ambulatory Surgery Center Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.7. Homecare Settings
    • 9.7.1. Homecare Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.8. Long-Term Care Facilities
    • 9.8.1. Long-Term Care Facilities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 9.9. Others
    • 9.9.1. Long-term Care (residential living setting) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Participant Categorization
  • 10.2. Key Company Profiles
  • 10.3. Company Share Analysis, 2024
    • 10.3.1. Medline Industries, LP.
      • 10.3.1.1. Company Overview
      • 10.3.1.2. Financial Performance
      • 10.3.1.3. Product Benchmarking
      • 10.3.1.4. Strategic Initiatives
    • 10.3.2. Coloplast Corp
      • 10.3.2.1. Company Overview
      • 10.3.2.2. Financial Performance
      • 10.3.2.3. Product Benchmarking
      • 10.3.2.4. Strategic Initiatives
    • 10.3.3. Molnlycke Health Care AB
      • 10.3.3.1. Company Overview
      • 10.3.3.2. Financial Performance
      • 10.3.3.3. Product Benchmarking
      • 10.3.3.4. Strategic Initiatives
    • 10.3.4. Solventum
      • 10.3.4.1. Company Overview
      • 10.3.4.2. Financial Performance
      • 10.3.4.3. Product Benchmarking
      • 10.3.4.4. Strategic Initiatives
    • 10.3.5. Convatec Inc.
      • 10.3.5.1. Company Overview
      • 10.3.5.2. Financial Performance
      • 10.3.5.3. Product Benchmarking
      • 10.3.5.4. Strategic Initiatives
    • 10.3.6. Cresilon
      • 10.3.6.1. Company Overview
      • 10.3.6.2. Financial Performance
      • 10.3.6.3. Product Benchmarking
      • 10.3.6.4. Strategic Initiatives
    • 10.3.7. Smith+Nephew
      • 10.3.7.1. Company Overview
      • 10.3.7.2. Financial Performance
      • 10.3.7.3. Product Benchmarking
      • 10.3.7.4. Strategic Initiatives
    • 10.3.8. B. Braun SE
      • 10.3.8.1. Company Overview
      • 10.3.8.2. Financial Performance
      • 10.3.8.3. Product Benchmarking
      • 10.3.8.4. Strategic Initiatives
    • 10.3.9. DermaRite Industries, LLC.
      • 10.3.9.1. Company Overview
      • 10.3.9.2. Financial Performance
      • 10.3.9.3. Product Benchmarking
      • 10.3.9.4. Strategic Initiatives
    • 10.3.10. Integra LifeSciences Corporation
      • 10.3.10.1. Company Overview
      • 10.3.10.2. Financial Performance
      • 10.3.10.3. Product Benchmarking
      • 10.3.10.4. Strategic Initiatives
    • 10.3.11. Sanara MedTech Inc.
      • 10.3.11.1. Company Overview
      • 10.3.11.2. Financial Performance
      • 10.3.11.3. Product Benchmarking
      • 10.3.11.4. Strategic Initiatives